COLANIC ACID

[31] Sevag MG, 1934, BIOCHEM Z, V273, P419

[32] IV. A biochemical study of the capsular substance. [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1927, 46 (01) : 155 - 166

[33] II. Mutations and their immunological significance. [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1927, 46 (01) : 133 - U6

[34] Studies on pathogenic B. Coli from bovine sources. I. The pathogenic action of culture filtrates. [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1927, 46 (01) : 123 - 131

[35] SMITH T, 1927, J EXP MED, V46, P1941

[36] A new culture medium for the production of antigenic streptococcal h ae molysin [J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1932, 35 (06): : 973 - 974

[37] WHITESIDE RA, PERSONAL COMMUNICATI

[38] WHITESIDE RE, 1959, J IMMUNOL, V83, P687

[31] Sevag MG, 1934, BIOCHEM Z, V273, P419

[32] IV. A biochemical study of the capsular substance. [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1927, 46 (01) : 155 - 166

[33] II. Mutations and their immunological significance. [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1927, 46 (01) : 133 - U6

[34] Studies on pathogenic B. Coli from bovine sources. I. The pathogenic action of culture filtrates. [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1927, 46 (01) : 123 - 131

[35] SMITH T, 1927, J EXP MED, V46, P1941

[36] A new culture medium for the production of antigenic streptococcal h ae molysin [J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1932, 35 (06): : 973 - 974

[37] WHITESIDE RA, PERSONAL COMMUNICATI

[38] WHITESIDE RE, 1959, J IMMUNOL, V83, P687